Sorry, this entry is only available in Polish.
Powiązane
Legal Alert | Advertising of food supplements – changes
On the website of the Government Legislation Centre on January 2 this year, a draft act amending the act on…
23 Jan 2023
SK&S advised AniCura on partnership with veterinary clinic “Animal”
We are pleased to inform that veterinary clinic “Animal” located in Łódź has joined AniCura, a family of leading veterinary…
13 Mar 2023
New regulations regarding restrictions on the sale of energy drinks are now in force!
On January 1, 2024, an amendment to the Public Health Act entered into force, revolutionizing the energy drinks market in…
13 Feb 2024
Legal Alert | Status of the CBD in 2024 – summary
The hemp market includes food products, cosmetic products, but also pharmaceutical raw materials or products for animals. What should an…
27 Feb 2024
Medicinal products, medical devices, biocidal products in the context of the COVID-19 epidemic
RESTRICTIONS ON TRADE Adding more products to the anti-export list (the requirement to report export to the Chief Pharmaceutical Inspectorate (GIF) 30 days…
25 Mar 2020
Polish chapter of “The Life Sciences Law Review – Edition 6” authored by Ewa Skrzydło-Tefelska and Jacek Myszko
We are pleased to inform that “The Life Sciences Law Review – Edition 6” has been published. Polish chapter authored…
15 Jun 2018
SK&S advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań,…
25 Apr 2024
Legal Alert | The President of the OCCP announces greater supervision of the pharmaceutical industry
During a January meeting of the Parliamentary Committee on Economy and Development,[1] the President of the Office of Competition and…
07 Feb 2023
Legal Alert | New guidelines for borderline products
An updated guideline for borderline products has been published on the European Commission website. For many product categories (e.g. medical…
07 Mar 2024
SK&S advised Velocity Clinical Research on the acquisition of ClinMedica Research
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
09 Feb 2024
SK&S advised AniCura on partnership with veterinary clinic “Wróblewscy”
We are pleased to inform that veterinary clinic “Wróblewscy” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
15 Mar 2023
Issues regarding borderline products – medical devices & medicinal products
The introduction of Regulation (EU) 2017/745 on Medical Devices (“MDR”) gave rise to a number of questions regarding products which…
09 Aug 2022
Legal Alert | Energy drinks for persons over the age of 18
In July last year, we reported that due to ongoing discussions, the possibility of limiting the sale of energy drinks…
18 Jul 2023
Legal Alert | The NSA allows the sale of alcohol over the Internet
The NSA allows the sale of alcohol over the Internet The Supreme Administrative Court (NSA), in a judgment dated September…
18 Jan 2023
SK&S recommended in the Legal500 ranking – 2024
We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…
28 Mar 2024